v3.26.3
PharmAla License Agreement and Share-Settlement Liability (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Aug. 20, 2026
Jul. 31, 2026
Jul. 20, 2026
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
May 19, 2026
Dec. 31, 2025
Share settlement obligation amount   $ 1,833,333       $ 1,833,333    
Cash obligation           1,058,546    
Equity consideration amount       $ 889,478   889,478      
Loss on fair value of license       (114,691) (114,691)    
Consideration payable       1,058,546   1,058,546    
Pharm Ala Biotech Holdings Inc. [Member]                  
Aggregate payment amount     $ 1,500,000            
Share settlement obligation amount     1,833,333 1,833,333          
Escrow deposit               $ 600,000  
License agreements     $ 900,000            
Cash consideration 314,396   314,396            
Stock issued 132,867                
Outstanding shares 181,529                
Cash obligation $ 1,058,546     1,058,546          
Equity consideration amount $ 889,478     889,478          
Reset price per share $ 5.8313                
Loss on fair value of license $ 114,691     114,691          
Consideration payable       $ 1,058,546   $ 1,058,546